Chest
Volume 104, Issue 6, December 1993, Pages 1673-1675
Journal home page for Chest

clinical investigations: Cardiovascular and Cardiac Surgery: Journal Article
The Prevalence and Significance of a Patent Foramen Ovale in Pulmonary Hypertension

https://doi.org/10.1378/chest.104.6.1673Get rights and content

In order to determine the prevalence and significance of a patent foramen ovale (PFO) in pulmonary hypertension, 58 patients were studied with transesophageal echocardiography, right-sided heart catheterization, and exercise testing. In order to examine if a PFO might be associated with a better outcome, survival was estimated, based on a formula derived from the National Institutes of Health Primary Pulmonary Hypertension Registry, for the patients with primary pulmonary hypertension (PPH). A PFO was found in 26 percent (15 of 58) of all patients studied, 25 percent (10 of 40) of those with PPH, and 28 percent (5 of 18) of those with secondary pulmonary hypertension. We found no significant difference in any hemodynamic variable or exercise tolerance between the patients with and without a PFO, or for subsets of patients with primary and secondary pulmonary hypertension. We also found no significant difference in the 1-, 2-, 3-, 4-, or 5-year estimated survival, for the patients with PPH between those with and without a PFO. The prevalence of a PFO in pulmonary hypertension appears similar to the normal population. A PFO provides no detectable influence on resting hemodynamics or exercise tolerance in patients with pulmonary hypertension and is not clearly associated with patients expected to survive longer.

Section snippets

Patients

Fifty-eight consecutive patients with pulmonary hypertension (44 female, 14 male), with a mean age of 42 ± 11 (range, 15 to 69) years, were studied. All patients were evaluated for the etiology of their pulmonary hypertension based on the protocol used in the National Institutes of Health Registry on Primary Pulmonary Hypertension.2 Pulmonary hypertension was diagnosed as primary in 40 patients (69 percent) and secondary in 18 (31 percent).

Patent Foramen Ovale Detection

Transesophageal echocardiography was performed using a

RESULTS

A PFO was present in 26 percent (15 of 58) of all patients studied, 25 percent (10 of 40) of the patients with PPH, and in 28 percent (5 of 18) of the patients with secondary pulmonary hypertension.

Hemodynamics, resting arterial oxygen saturation levels with patients breathing room air, and exercise times for the groups with and without a PFO are given in Table 1. The patients studied had severe pulmonary hypertension with a mean pulmonary artery pressure of 55 ± 15 mm Hg, pulmonary vascular

DISCUSSION

A PFO has been reported in 25 to 35 percent of normal patients at autopsy.5 Several retrospective studies have reported a prevalence from 12 to 31 percent in patients with PPH.1, 6, 7 The methods of detection, however, include right-sided heart catheterization and transthoracic echocardiography which, due to technical limitations, tend to underreport the actual prevalence.3 Recently, contrast transesophageal echocardiography was reported to be possibly the most sensitive and specific test for

APPENDIX

A proportional hazards model is used to predict survival of primary pulmonary hypertension (PPH) patients. The probability of a given PPH patient surviving past t years, given hemodynamic variables collected at baseline, is PD(t,x,y,z)=[H(t)]A(x,y,z), where H(t)=0.880.14t+0.01A2,A(x,y,z)=e0.007325x+0.0526y0.3275z, t ranges from one to five years, and the hemodynamic variables are x = mean pulmonary artery pressure, y = mean right atrial pressure, and z = cardiac index.

Cited by (51)

  • Agitated Saline Contrast Echocardiography in the Identification of Intra- and Extracardiac Shunts: Connecting the Dots

    2021, Journal of the American Society of Echocardiography
    Citation Excerpt :

    Conversely, multiple studies have looked at the effects of pulmonary hypertension on PFO detection and whether it would increase rates of detection. Interestingly, however, identification rates of a PFO are unchanged from that of the general population.55,56 Increased RV size and decreased RV function have been associated with increased PFO detection rates, whereas echocardiographically measured RV systolic pressure has not.56

  • Hypoxemia and PFO

    2019, Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia
  • Patent Foramen Ovale Closure for Hypoxemia

    2017, Interventional Cardiology Clinics
    Citation Excerpt :

    With time, the septum primum and secundum fuse leaving behind the fossa ovalis. For approximately 20% of the population this fusion remains incomplete, resulting in a PFO.4–6 In most people who have a PFO, it is an incidental finding and not associated with symptoms or hypoxemia.

  • Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity

    2016, Respiratory Medicine
    Citation Excerpt :

    Studies done in patients with PH secondary to sleep disorder breathing and chronic obstructive pulmonary disease) found an association between PFO presence and increased MPAP [25,26]. However, Nootens et al. in their study of 58 patients with PH of varied etiologies, found PFO had no correlation with any hemodynamic parameter as measured by RHC during rest [22]. As seen in patients with atrial septostomy, one may expect decreased right-sided pressures due to shunting at the expense of worsened hypoxemia, as well as improved cardiac output [14,16].

  • Right-to-left atrial shunting associated with aortic root aneurysm: A case report of a rare cause of platypnea-orthodeoxia syndrome

    2013, Heart Lung and Circulation
    Citation Excerpt :

    Reversal of the left-to-right atrial pressure differential can occur in association with the substantial haemodynamic changes caused by physiologic manoeuvres that increase right atrial pressure, such as posture change, inspiration, cough, or valsalva manoeuvres [13]. In addition, this pressure differential reversal can occur in association with pathologic conditions characterised by high pulmonary vascular resistance [14], such as acute pulmonary embolism [15], hypoxaemia due to obstructive sleep apnoea [16], severe chronic obstructive pulmonary disease [17], or right ventricular infarction [18]. The right-to-left atrial shunt in the platypnea–orthodeoxia syndrome occurs despite normal right atrial pressure and vascular pulmonary resistance.

View all citing articles on Scopus
View full text